|
Albea Pharmaceuticals intends to build through a series of acquisitions a rapidly growing, profitable, and fully integrated pan-European pharmaceutical company with a portfolio of marketed products, a direct sales and marketing organization in the major European countries (UK, Germany, France, Italy and Spain), and a pipeline of products in various stages of clinical development.
Acura
Pharmaceuticals is engaged in research and development of proprietary abuse deterrent
formulation technologies (the "Aversion™ Technology") intended to deter
the abuse of orally administered opioid analgesic products.
Amarin Corporation
is a specialty pharmaceutical company focused on pain management and
neurology.
AmeriFIT Nutrition Inc.
is a cutting edge, innovative leader in the nutritional supplement
industry, focused on building brands in the burgeoning women‚s health
and joint care categories.
Bradley Pharmaceuticals
develops and markets dermatological and respiratory products.
Using its proprietary CORPLEX hydrogel technology, Corium International develops, engineers, and manufactures drug delivery products and devices that utilize the skin and mucosa as a primary means of transport. Corium's product development and manufacturing expertise include Rx transdermal systems, OTC, personal care and wound care products, products requiring pressure-sensitive adhesives and medical diagnostics and devices.
Dow
Pharmaceutical Sciences
specializes in development of topical drug products for pharmaceutical
and biotechnology clients.
eNos
is a developmental stage company dedicated to the pursuit of innovative
therapies for treatment of cardiovascular disease, Alzheimer's disease,
and stroke.
EUSA Pharma Inc
is a new specialty pharmaceutical company focused on the major European
countries. EUSA intends to build a portfolio of products that are on the
market or in late-stage clinical trials through acquisitions and
in-licensing from the US. The company will build a sales and marketing
organization and commercial infrastructure in all major European
countries.
Healthcare Brands International (HBI) established in the UK in October 2006, participates primarily in the growing market of OTC Medicines and is committed to acquiring, developing and investing in differentiated healthcare products and translating them into meaningful consumer brands.
Horizon Therapeutics is a late stage biopharmaceutical company focused on rapid development of prescription drugs for mild to moderate pain relief. They create novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.
Inhibitex, Inc.
is a biopharmaceutical company developing first in field antibody
products for the treatment and prevention of staphylococcal and other
bacterial and fungal infections, using its proprietary MSCRAMMÂ
technology platform.
MediciNova, Inc.
is a specialty pharmaceutical company focused on acquiring and
accelerating the global development and commercialization of innovative
pharmaceutical products.
Palatin
is an emerging leader in pharmaceutical research and development in the
areas of drug discovery, pre-clinical/clinical research and product
development.
PediaMed Pharmaceuticals, Inc.
is devoted exclusively to the health of children, and provides
innovative products and services designed to help improve the well being
of infants, children, adolescents, and young adults.
Prism
Pharmaceuticals
is a
specialty pharmaceutical company committed to developing and
commercializing products for the prevention and management of
cardiovascular disease.
Formerly Control Delivery Systems, pSivida
identifies medical areas where traditional approved therapies have
failed to meet patient and physician needs, and then develops new
alternative solutions.
Receptor BioLogix, Inc.
is a biopharmaceutical company focused on developing a newly discovered
class of protein therapeutics to treat cancer, autoimmune, metabolic and
other diseases
Revance Therapeutics
is a specialty pharmaceutical company formed to discover, develop and
commercialize therapeutic products for treating chronic disease and
age-related changes to skin and soft tissue. The Company's core clinical
targets are in areas of aesthetic medicine and therapeutic dermatology.
Salix Pharmaceuticals, Ltd.
is a leading specialty pharmaceutical company providing solutions to
gastroenterologists and their patients.
Shire Pharmaceuticals Group
is an international specialty pharmaceutical company with a strategic
focus on four therapeutic areas: central nervous system disorders,
metabolic diseases, oncology and gastroenterology.
Xanodyne Pharmacal, Inc.
markets branded CNS, oncolytic and hematological products to oncologists
and pain specialists to improve quality of life for seriously ill
patients.
ZIOPHARM Oncology is
a biopharmaceutical company engaged in the development and
commercialization of a diverse, risk-sensitive portfolio of in-licensed
cancer drugs to address unmet medical needs.
|
